In recent years, major advances have been made in our understanding of the basic biology of aging, leading to the identification of novel interventions with potential to prolong healthspan. In spite of exciting studies in model organisms, there has been a lack of programs and infrastructure needed to enable the translation of these discoveries to humans. The major objective of the Pilot / Exploratory Studies Core (PESC) is to promote the overarching goals of the San Antonio Older Americans Independence Center (OAIC) by developing and validating interventions to enhance healthy aging and mitigate the progression of aging-associated processes and diseases. Indeed, the PESC plays a key role in the San Antonio OAIC's central theme of translational geroscience by supporting projects that move research on the basic biology of aging from the laboratory bench to the bedside, in order to extend healthy life expectancy. The PESC will provide merit-based support for rigorously designed pilot studies that test both the efficacy and side effect profiles of promising pharmacologic, as well as non-pharmacologic cell-based and behavioral interventions, in pre-clinical marmoset models and early human clinical studies. The PESC will strive to achieve its objectives through the following specific aims: ? Aim 1: To promote innovative, collaborative, multidisciplinary research to test interventions designed to extend healthy life expectancy, both in early human trials and in non-human primate marmoset models. ? Aim 2: To work closely with the Resource Cores and Research Education Component to provide infrastructure, scientific support, and funding for innovative pilot proposals from mentored junior faculty investigators, as well as established researchers. ? Aim 3: To encourage pilot studies that will develop and apply novel methods and technologies. ? Aim 4: To sustain effective processes to solicit, review, and fund pilot projects, as well as ensure study completion, robust tracking of downstream impact, and optimal dissemination and implementation. The Core leaders, having a great deal of experience directing successful pilot project programs, will promote key alignments and interactions of PESC investigators with OAIC Resource Cores, as well as with resources in the broader scientific community. The Core will provide close oversight and guidance to PESC-supported studies from inception, during the investigative and analytical phases, through publication, and ultimately through the submission of proposals for competitive national grant funding. The PESC will seek proposals on rapidly evolving age-related scientific areas such as resilience ? the capacity to return to normal functional homeostasis after stress exposure. To address the shrinking pipeline of qualified translational investigators the PESC is committed to funding meritorious proposals from early-stage investigators. Finally, we have received significant leveraging commitments, enabling PESC project investments of $290K annually and positioning the PESC to achieve both a robust return on investment and significant impact on translational geroscience.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG044271-06
Application #
10028130
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Salmon, Adam B; Dorigatti, Jonathan; Huber, Hillary F et al. (2018) Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions. Geroscience 40:269-278
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Sills, Aubrey M; Artavia, Joselyn M; DeRosa, Brian D et al. (2018) Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol :e22927
Noël, Polly Hitchcock; Wang, Chen-Pin; Finley, Erin P et al. (2018) Provider-Related Linkages Between Primary Care Clinics and Community-Based Senior Centers Associated With Diabetes-Related Outcomes. J Appl Gerontol :733464818782853
Reveles, Kelly R; Mortensen, Eric M; Koeller, Jim M et al. (2018) Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans. Pharmacotherapy 38:349-356
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ipson, B R; Fletcher, M B; Espinoza, S E et al. (2018) Identifying Exosome-Derived MicroRNAs as Candidate Biomarkers of Frailty. J Frailty Aging 7:100-103
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :

Showing the most recent 10 out of 22 publications